Utility of the surgical apgar score: validation in 4119 patients.
OBJECTIVE
To confirm the utility of a 10-point Surgical Apgar Score to rate surgical outcomes in a large cohort of patients.


METHODS
Using electronic intraoperative records, we calculated Surgical Apgar Scores during a period of 2 years (July 1, 2003, through June 30, 2005).


METHODS
Major academic medical center.


METHODS
Systematic sample of 4119 general and vascular surgery patients enrolled in the National Surgical Quality Improvement Program surgical outcomes database at a major academic medical center.


METHODS
Incidence of major postoperative complications and/or death within 30 days of surgery.


RESULTS
Of 1441 patients with scores of 9 to 10, 72 (5.0%) developed major complications within 30 days, including 2 deaths (0.1%). By comparison, among 128 patients with scores of 4 or less, 72 developed major complications (56.3%; relative risk, 11.3; 95% confidence interval, 8.6-14.8; P < .001), of whom 25 died (19.5%; relative risk, 140.7; 95% confidence interval, 33.7-587.4; P < .001). The 3-variable score achieves C statistics of 0.73 for major complications and 0.81 for deaths.


CONCLUSIONS
The Surgical Apgar Score provides a simple, immediate, objective means of measuring and communicating patient outcomes in surgery, using data routinely available in any setting. The score can be effective in identifying patients at higher- and lower-than-average likelihood of major complications and/or death after surgery and may be useful for evaluating interventions to prevent poor outcomes.
Regenbogen
Scott E
SE
Department of Health Policy and Management, Harvard School of Public Health, 677 Huntington Ave, Boston, MA 02115, USA. sregenbogen@partners.org
Ehrenfeld
Jesse M
JM
Lipsitz
Stuart R
SR
Greenberg
Caprice C
CC
Hutter
Matthew M
MM
Gawande
Atul A
AA
D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D011183:Postoperative Complications / Q000453:epidemiology; D013514:Surgical Procedures, Operative / Q000009:adverse effects / Q000592:standards*